top of page

Our News 

Recent News Stories, Press Releases, and Company Announcements

12/09/2021

Hememics_Biotechnologies_Inc_Logo_edited_edited.png

COVID-19 Rapid Test Kits Global Market Report 2021
ResearchandMarkets.com

Hememics Biotechnologies Inc. partnered with Biomedical Research and Development Authority (BARDA) to develop a rapid antibody and antigen diagnostic tool.

09/08/2021

Graphene Biosensor Evolution: The Practical Applications of Graphene

Graphene's unique properties provide some very practical applications in biosensors. 

Screenshot 2022-08-12 145837.png

06/01/2021

Hememics_Biotechnologies_Inc_Logo_edited_edited.png

Hememics Biotechnologies Inc. Receives $400k Investment From Dai Viet Inc.

Dai Viet invests $400k into Hememics. 

09/28/2020

Not All COVID-19 Tests Are Created Equal  - New Biosensors to Improve Speed and Connectivity

As the COVID-19 pandemic rages on, Hememics Biotechnologies's Biosensors are redefining rapid tests. 

Screen Shot 2022-08-04 at 2.50.02 PM.png

09/17/2020

Dai Viet.jpeg

Dai Viet Signs for Investment Cooperation with Hememics Biotechnologies Inc. USA

Dai Viet group invests in Hememics.

07/13/2020

NOVA Investors Band Together and Invest in Hememics

Local businesses and entities in Northern Virginia (NOVA) have banded together to invest in Hememics. 

Hememics_Biotechnologies_Inc_Logo_edited.png

05/29/2020

Screen Shot 2022-08-05 at 10.03.15 AM.png

Biosensors May Hold the Key to Mass Coronavirus Testing

Dry proteins are Hememics "Special Sauce" in antigen detection.

04/22/2020

New Coronavirus Test Could Diagnose the Virus in 60 Seconds or Less

The potential for the Hememics biosensor to detect COVID in under a minute has the potential to address a critical issue in identifying those with active infections vs those with antibodies.

Screen Shot 2022-08-04 at 3.04.22 PM.png
Screen Shot 2022-12-20 at 10.42.36 AM.png

12/11/2019

Hememics Biotechnologies Inc. Received a $2.5 Million Investment from AMVI Partners

Hememics Biotechnologies received support from investment firm AMVI and plans to utilize the funds in the development and commercialization of Hememics technologies.

12/20/2017

Inova Personalized Health Accelerator Accepts Hememics Biotechnologies, Inc. Into Portfolio

Hememics enters Inova investment portfolio.

Screen Shot 2022-08-04 at 3.29.38 PM.png
bottom of page